A carregar...
Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19
Abstract–In this article, we provide guidance on how safety analyses and reporting of clinical trial safety data may need to be modified, given potential impact from the COVID-19 pandemic. Impact could include missed visits, alternative methods for assessments (such as virtual visits), alternative l...
Na minha lista:
| Publicado no: | Stat Biopharm Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8011485/ https://ncbi.nlm.nih.gov/pubmed/34191982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2020.1804444 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|